HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunscreen labeling

This article was originally published in The Rose Sheet

Executive Summary

FDA reviewing sunscreen reapplication/water resistance research proposal from American Cancer Society. The organization is considering conducting a consumer perception survey and holding a scientific conference to define questions of sunscreen protection deterioration; ACS is requesting FDA feedback on the proposal. The group petitioned FDA in February to consider adding a requirement to the sunscreen regulation that labeling delineate how long a sun protection product would last after sweating or swimming. In its response, the agency asked ASC for specific water resistance and sunscreen reapplication data (1"The Rose Sheet" April 10, p. 8)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel